| Financial Year |
March 31 2023 |
| Monetary Funds |
1,300,345,638.96 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
63,260,452.63 |
| Accounts Receivable |
3,128,853,914.31 |
| Advances to Suppliers |
176,224,898.47 |
| Other Receivables |
54,540,595.96 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,416,227,533.97 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
154,287,960.17 |
| Total Current Assets |
7,384,021,896.10 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
94,097,412.00 |
| Long-term Equity Investment |
24,018,522.18 |
| Investment Properties |
-- |
| Fixed Assetes |
2,921,081,438.91 |
| Under-construction Projects |
290,969,473.81 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
344,570,400.07 |
| R&D expenses |
272,546,851.92 |
| Goodwill |
716,052,052.94 |
| Long-Term Deferred and Prepaid Expenses |
58,891,033.76 |
| Deferred Income Tax Assets |
104,229,711.25 |
| Other Non-Current Assets |
57,159,491.65 |
| Sub-Total of Non-Current Assets |
5,226,165,742.91 |
| Total Assets |
12,610,187,639.01 |
| Short-Term Loans |
157,352,806.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
11,285,393.81 |
| Accounts Payable |
911,498,588.03 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,106,512.38 |
| Taxes Payable |
59,986,098.83 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
783,403,835.79 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
241,370,180.84 |
| Other Current Liabilities |
69,094,535.57 |
| Sub-Total of Current Liabilities |
2,381,681,962.73 |
| Long-term Loans |
854,324,939.90 |
| Bonds Payable |
598,167,495.96 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,370,229.51 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,589,730,137.29 |
| Total Liabilities |
3,971,412,100.02 |
| Paid-In Capital(Or Share Stock) |
3,004,154,837.00 |
| Capital Surplus |
589,488,103.47 |
| Surplus Reserve |
262,422,657.01 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,608,805,101.30 |
| Minority Stockholder's Interest |
176,145,875.33 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,462,629,663.66 |
| Owner's Equity（Stockholder's Equity） |
8,638,775,538.99 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,610,187,639.01 |
